These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 30006314)

  • 1. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
    Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
    Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.
    Chen C; Zhou JL; Han X; Song F; Wang XL; Wang YZ
    Nanotechnology; 2014 Jun; 25(25):255101. PubMed ID: 24896540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin.
    Kim N; Kwon S; Kwon G; Song N; Jo H; Kim C; Park S; Lee D
    J Control Release; 2024 May; 369():351-362. PubMed ID: 38552963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery.
    Du C; Deng D; Shan L; Wan S; Cao J; Tian J; Achilefu S; Gu Y
    Biomaterials; 2013 Apr; 34(12):3087-97. PubMed ID: 23374705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug.
    Shanmugam V; Chien YH; Cheng YS; Liu TY; Huang CC; Su CH; Chen YS; Kumar U; Hsu HF; Yeh CS
    ACS Appl Mater Interfaces; 2014 Mar; 6(6):4382-93. PubMed ID: 24559392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.
    Zhang Y; Xiao C; Li M; Chen J; Ding J; He C; Zhuang X; Chen X
    Macromol Biosci; 2013 May; 13(5):584-94. PubMed ID: 23420692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo.
    Tarasenko N; Cutts SM; Phillips DR; Berkovitch-Luria G; Bardugo-Nissim E; Weitman M; Nudelman A; Rephaeli A
    Biochem Pharmacol; 2014 Mar; 88(2):158-68. PubMed ID: 24463168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyprodrug nanomedicine for chemiexcitation-triggered self-augmented cancer chemotherapy and gas therapy.
    Wang Q; Zhang C; Zhao Y; Jin Y; Zhou S; Qin J; Zhang W; Hu Y; Chen X; Yang K
    Biomaterials; 2024 Sep; 309():122606. PubMed ID: 38776593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic Acid-multiwalled carbon nanotube conjugate.
    Das M; Datir SR; Singh RP; Jain S
    Mol Pharm; 2013 Jul; 10(7):2543-57. PubMed ID: 23683251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum covalent shell cross-linked micelles designed to deliver doxorubicin for synergistic combination cancer therapy.
    Zhu C; Xiao J; Tang M; Feng H; Chen W; Du M
    Int J Nanomedicine; 2017; 12():3697-3710. PubMed ID: 28553108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate.
    Smith GK; Banks S; Blumenkopf TA; Cory M; Humphreys J; Laethem RM; Miller J; Moxham CP; Mullin R; Ray PH; Walton LM; Wolfe LA
    J Biol Chem; 1997 Jun; 272(25):15804-16. PubMed ID: 9188478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer.
    Zhang Y; Yang C; Wang W; Liu J; Liu Q; Huang F; Chu L; Gao H; Li C; Kong D; Liu Q; Liu J
    Sci Rep; 2016 Feb; 6():21225. PubMed ID: 26876480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic polymer prodrug-based unimolecular micelles for pH-responsive co-delivery of doxorubicin and camptothecin with synergistic controlled drug release effect.
    Chen W; Liu P
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113906. PubMed ID: 38615388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines.
    Wang Y; Liu D; Zheng Q; Zhao Q; Zhang H; Ma Y; Fallon JK; Fu Q; Haynes MT; Lin G; Zhang R; Wang D; Yang X; Zhao L; He Z; Liu F
    Nano Lett; 2014 Oct; 14(10):5577-83. PubMed ID: 25188744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.